Lv1
36 积分 2022-07-22 加入
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
3小时前
已完结
Targeted Degradation of DDR1 by Proteolytic Targeting Chimera Reverses Immune Exclusion for Tumor Immunotherapy
5天前
已完结
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
6天前
已完结
Targeted Degradation of DDR1 by Proteolytic Targeting Chimera Reverses Immune Exclusion for Tumor Immunotherapy
11天前
已完结
Proteome-scale discovery of protein degradation and stabilization effectors
27天前
已完结
Multiple anti-tumor programs are activated by blocking BAD phosphorylation
28天前
已完结
Increase recombinant antibody yields through optimizing vector design and production process in CHO cells
1个月前
已完结
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
1个月前
已完结
pH-sensitive prodrugs
1个月前
已完结
Advancements of prodrug technologies for enhanced drug selectivity in pharmacotherapies
1个月前
已完结
皖公网安备34019202002308
